Patrizia Popoli is president of the Cts of Aifa: interview from The newspaper, tried to clarify the doubts and fears unleashed on AstraZeneca, the Anglo-Swedish vaccine on which scientific communication has made water on all sides, also misleading politics. First of all, Popoli clarified the risk of thrombotic events related to the recall with AstraZeneca: “In Italy no case has been reported following the second dose. From the data coming from abroad it seems that the adverse reactions are almost 10 times lower than the first dose: after the first about one in 100 thousand, after the second about one in a million “.
So if these are the data, why impose the vaccine mix? “It is a type of risk considered acceptable when the viral circulation is high and the risk of dying or getting sick is also there for young people. On the other hand, when the virus circulates little (as now) the risk-benefit ratio changes, and the indications must change accordingly ”, replied the president of the Aifa CTS. Which therefore he would not have proposed open days for boys: he did not openly call them a mistake, but he hinted that they could be avoided because there was no urgency.
As for the vaccine mix, science is divided and the former director of Aifa spoke of weak data: “It is true – Popoli admitted – we do not have solid data as for homologous vaccination, but there is a strong theoretical basis. We have limited studies, about 800 cases in the UK and 700 in Spain, but the same EMA had released a report to the States in which it had hypothesized the mix of vaccines as a scenario ”.